PMDA drug package insert
ナビゲート顆粒「分包」
PMDA OTC drug · 日邦薬品工業（株） · package insert May 12, 2020
Key facts
| Brand names | ナビゲート顆粒「分包」 |
|---|---|
| Companies | 製造販売元／日東薬品工業（株）,販売会社／日邦薬品工業（株） |
| Product type | OTC drug |
| OTC risk class | 第２類医薬品 |
| OTC dosage form | 散剤 |
| OTC effect category | 漢方製剤 |
| Package insert date | May 12, 2020 |
| PMDA document key | 530143_J0601001653 |
| PMDA company code | 530143 |
At a glance
- 1–9 Package insert revisions
- None Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: